Skip to main content
. 2014 Mar 3;20:200–214.

Table 5. Association analysis of polymorphisms in multivariate models.

Gene SNP genotype Ajusted OR (CI) P value
KDR
rs2071559
TT

0.05

CT
1.57 (1.01,2.44)


CC
1.87 (1.01,3.48)

rs1870377
TT

0.64

TA
1.13 (0.69,1.85)


AA
0.88 (0.48,1.6)

rs1870378
GG

0.79

GA
1.1 (0.66,1.81)


AA
0.91 (0.5,1.66)

rs13109660
GG

0.93

GA
1.01 (0.48,2.13)


AA
1.09 (0.7,1.68)

VEGF
rs699947
CC

0.002

CA
1.26 (0.82,1.95)


AA
3.74 (1.75,8.00)

rs833061
TT

0.004

CT
1.19 (0.77,1.85)


CC
3.50 (1.62,7.54)

rs13207351
GG

0.002

GA
1.22 (0.79,1.89)


AA
3.64 (1.71,7.77)

rs2146323
CC

0.014

CA
1.14 (0.73,1.77)


AA
2.88 (1.4,5.93)

rs3025021
TT



CT
0.75 (0.2,2.78)
0.22

CC
1.14 (0.32,4.06

rs833069
GG



GA
1.09 (0.63,1.89)
0.63

AA
1.3 (0.73,2.34)

rs2010963
GG



GC
0.89 (0.56,1.41)
0.51

CC
0.7 (0.38,1.28)

rs3025039
CC

0.23

CT
1.23 (0.79,1.92)


TT
2.8 (0.76,10.27)

ICAM-1
rs5498
AA

0.091

GA
1.44 (0.94,2.22)


GG
2.04 (0.94,4.44)

EPO
rs507392
TT

0.88

CT
1.02 (0.65,1.61)


CC
0.8 (0.32,2.02)

rs551238
AA

0.94

CA
1.07 (0.67,1.68)


CC
0.92 (0.36,2.36)

rs1617640
TT



GT
0.85 (0.53,1.36)
0.79

GG
0.94 (0.36,2.41)

AKR1B1
759853
GG

0.11

GA
0.62 (0.39,0.99)


AA
0.59 (0.17,2.05)

ACE
1800764
TT

0.33

CT
0.87 (0.56,1.37)


CC
0.62 (0.33,1.16)

rs9896208
CC



TC
0.62 (0.39,0.97)
0.097

TT
0.88 (0.47,1.63)

PRK-β 3900007
AA

0.82

GA
1.14 (0.72,1.8)


GG
1.17 (0.64,2.14)

2575390
CC

0.78

CG
0.89 (0.46,1.71)


GG
2.73 (0.1,73.85)

3760106
GG

0.81

GA
2.67 (0.1,71.35)

AA 0.92 (0.48,1.77)

Multiple logistic regression analysis was used to calculate odds ratio (OR) and 95% confidence interval (CI) by comparing diabetic retinopathy (DR) group with diabetic without retinopathy (DWR) group, which include the most significant SNP at kinase insert domain receptor gene (KDR) gene (rs2071559), vascular endothelial growth factor (VEGF) gene (rs833061, rs13207351, rs699947, rs2146323). Adjusted OR represents data after adjustment for covariates including age of diabetic onset, duration, high albuminuria, insulin use, glycosylated hemoglobin A1c (HbA1c), fasting plasma glucose and creatinine levels.